Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients

Diabetes

Volumn 45, Issue 2, 1996, Pages 216-222

  Velussi, Mario ^a   Brocco, Enrico ^d   Frigato, Francesco ^b   Zolli, Mario ^c   Muollo, Bruno ^d   Maioli, Mario ^e   Carraro, Andrea ^d   Tonolo, Giancarlo ^e   Fresu, Pietro ^d,e   Cernigoi, Anna Maria ^a   Fioretto, Paola ^d,e   Nosadini, Romano ^d  

^a Centro Antidiabetico di Monfalcone   (Italy)

^b Centro Antidiabetico di Mestre   (Italy)

^c Centro Antidiabetico di Mirano   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CHROMIUM CR 51; FUROSEMIDE; HEMOGLOBIN A1C; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9044235779     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.2.216     Document Type: Article

References (38)

1. Raine AEG: Epidemiology, development and treatment of end-stage renal failure in type II (nun-insulin-dependent) diabetic patients in Europe. Diabetologia 36:1099-1104, 1993
2. The 1993 USRDS Annual Data Report: incidence and causes of treated ESRD. Am J Kidney Dis 22 (Suppl. 2):38-45, 1993
3. La Greca G, Catalano C, Dell'Aqiula R, Earle G, Milan M, Fruner L, Disegna D: Epidemiology of kidney failure in diabetic patients in Italy. Acta Diabetol 34:167-172, 1992
4. Viberti GC, Wiseman MJ: The kidney in diabetes: significance of the early abnormalities. Clin Endocrinol Metab 15:753-782, 1986
5. Mogensen CE, Schmitz A, Christensen CK: Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev 4.453-483, 1988
6. Friedman R, Gross J: Evolution of glomerular filtration rate in proteinuric NIDDM patients. Diabetes Care 14:355-359, 1991
7. Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FIR: Clinical and histological correlation of decline in renal function in diabetic patients with proteinuria. Diabetes 43:1046-1051, 1994
8. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
9. Tolins JP, Raij L: Angiotensin converting enzyme inhibitors and progression of chronic renal failure. Kidney Int 38 (Suppl. 30):S118-S122, 1990
10. Lewis EJ, Hunsicker LG, Bain R, Rohde RD: The effect of angiotensin-converting inhibition on diabetic nephropathy. N Engl J Med 329:1456-1463, 1993
11. Mathiesen ER, Hommel E, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br Med J 303:81-84, 1991
12. Viberti GC, Mogensen CE, Groop LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-282, 1994
13. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 302:210-216, 1991
14. Chan J, Cockram C, Nicholls M, Cheung C, Swaminathan R: Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: one year analysis Br Med J 305:981-985, 1992
15. Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M: Long-term effect of ACE-inhibition on development of nephropathy in diabetes mellitus type II. Kidney Int 45:S161-S164, 1994
16. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of high blood pressure (JNC-V). Arch Intern Med 153:154-183, 1993
17. American Diabetes Association: Treatment of hypertension in diabetes. Diabetes Care 16:1394-1401, 1993
18. National Diabetes Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 26:1039-1057, 1979
19. Criteria Committee of the New York Heart Association: Disease of the Heart and Blood Vessels. 6th ed. Boston, MA, Little Brown, 1964
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
21. Veall N, Gibbs GP: The accurate determination of tracer clearance rates and equilibrium distribution volume from single injection plasma measurements using numerical analysis. In Radionuclides in Nephrology. Joekes AM, Constable AR, Brown NJM, Tranxe WN, Eds. London, Academic Press, 1982, New York, Grune and Strutton, 1982, p. 125-130
22. Pacini G, Thomaseth K, Sambataro M, Nosadini R, Crepaldi G: Assessment of renal function: accurate determination of glomerular filtration rate, renal plasma flow and extracellular fluid volume. In Current Topics in Diabetes Research. Vol. 12. Belfiore F, Bergman R, Molinatti GM, Eds. Front Diabetes, Karger, Basel, 1993, p 257-260
23. Dunn PJ, Cole RA, Soeldner JS: Further development and automation of a high pressure liquid chromatographic method for the determination of HbA1c. Metabolism 28:777-779, 1979
24. Care RN, Feldbruegger D, Westgard J: Evaluation of the adaptation of the glucose peroxide 3-methyl-2 benzothiazolinone hydrazone-N-N dimethyline procedure to the technicon "SMA" 12/60 and comparison with other automated methods of glucose. Clin Chem 20:595-602, 1974
25. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Crepaldi G: Prevalence of hypertension and microalbuminuria in adult IDDM patients without renal failure in Italy: validation of screening techniques to detect microalbuminuria. Acta Diabetol 29.156-166, 1992
26. Zar J: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1984
27. Lehovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schwartz S, Mengel M, Segal R, Versaggi JA, Belton K: Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 45:S150-S155, 1994
28. Walker WG, Hermann J, Anderson J, Zachary J, Russel RP: Blood pressure control slows decline of GFR in hypertensive NIDDM patients (Abstract). J Am Soc Nephrol 3:339A, 1993
29. Mauer M: Structural-functional correlations of diabetic nephropathy. Kidney Int 45 612-622, 1994
30. Gall MA, Nielsen FS, Smidt UM, Parving HH: The course of kidney function in type 2 NIDDM patients with diabetic nephropathy. Diabetologia 36:1071-1078, 1993
31. Fioretto P, Mauer M, Brocco E, Velussi M, Muollo B, Sambataro M, Crepaldi G, Borsatti A, Nosadini R Heterogeneity in renal structure in non-proteinuric type 2 diabetic patients (Abstract). Diabetologia 38:A217, 1995
32. Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17:1247-1251, 1994
33. Kasiske BL, Kalil R, Ma J, Lia M, Keane W: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129-138, 1993
34. Weidmann P, Boehlen LM, de Courten M: Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8:582-584, 1993
35. Bakris G, Barnhill B, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 41: 912-919, 1992
36. Fioretto P, Frigato F, Velussi M, Riva F, Muollo B, Carraro A, Brocco E, Cipollina MR, Abbaterusso C, Trevisan M, Crepaldi G, Nosadini R: Effects of angiotensin converting enzyme inhibitors and calcium antagonists on ANP release and action and on albumin excretion rate. Am J Hypertens 5:890-900, 1992
37. The Diabetes Control and Complications Trial Research Group: The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977, 1993
38. Krolewski A, Laffel L, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with IDDM. N Engl J Med 332:1251-1255, 1995